Tokyo · Peptide & Life Sciences

Your Global Partner
in Peptide &
Life Sciences

We bridge global pharmaceutical companies with peptide raw material suppliers, CDMO manufacturers worldwide, and Japan's leading healthcare facilities.

J & K L 株式会社
Jaisy und Kraft für Leben
Get in Touch
Peptide Research Lab
10+
Years in Pharma
3
Core Markets
CN · JP · EU
Coverage
Located in Tokyo,
Serving the World

J & K L 株式会社 is a Tokyo-based consultancy focused on the global peptide and life sciences industry. We specialize in peptide raw material sourcing, CDMO matchmaking across China, Japan and beyond, and health management advisory. With deep roots in Asian and European markets, we connect clients worldwide with the best partners in peptide manufacturing and advanced healthcare.

01

Peptide Raw Material Procurement

Intermediary for global peptide API, intermediates and custom synthesis — connecting buyers with verified suppliers.

02

China CDMO & Factory Sourcing

We specialize in connecting European, Japanese, and U.S. pharma companies with China-based peptide contract manufacturers — from SPPS specialists to GMP-certified commercial facilities.

03

Health Management in Japan

We guide clients to Japan's leading stem cell clinics, anti-aging centers and premium wellness facilities.

Our Services

Three specialized service pillars focused on the global peptide industry and life sciences ecosystem.

01

Peptide Raw Material Procurement

We act as trusted intermediaries sourcing peptide APIs, key intermediates, and custom synthesis materials — connecting global buyers with qualified suppliers at competitive prices.

  • Peptide API & intermediate sourcing
  • Custom peptide synthesis coordination
  • Supplier qualification & audit support
  • Cross-border import/export coordination
02

China CDMO & Factory Sourcing

We specialize in helping European, Japanese, and U.S. pharma and biotech companies identify and engage China-based peptide contract manufacturers — from clinical-stage SPPS specialists to large-scale commercial GMP facilities.

  • China peptide factory identification & shortlisting
  • GMP facility assessment & on-site due diligence
  • Technical & regulatory gap analysis
  • Bilingual negotiation & contract support
03

Health Management Consulting

We provide personalized health management advisory and help clients access Japan's most advanced regenerative medicine and wellness facilities — including stem cell therapies and anti-aging programs.

  • Stem cell clinic consultation & referral
  • Anti-aging & regenerative medicine programs
  • Comprehensive health check coordination
  • Medical travel planning in Japan
From First Contact to Closed Deal

A clear, bilingual process designed to move fast and reduce friction across borders.

01

Initial Consultation

We start with a focused conversation to understand your exact requirements, timelines, and compliance needs.

02

Solution Matching

We draw from our verified supplier and CDMO network to identify the best-fit partners for your project.

03

Resource Bridging

We facilitate introductions, support due diligence, and provide bilingual negotiation throughout the process.

04

Ongoing Support

We stay engaged post-introduction to ensure smooth execution and address any issues that arise along the way.

Why Work With Us

Three things that set us apart in the global peptide and life sciences space.

🌐
Trilingual Team

Chinese · English · German

Our team operates natively across three languages, eliminating miscommunication at every stage — from supplier negotiation in Mandarin to client reporting in English or German.

🔬
Peptide Focus

Deep Expertise, Narrow Scope

We focus exclusively on peptides and life sciences — not generalist sourcing. This means deeper supplier relationships, faster qualification, and sharper technical judgment on your behalf.

🗺️
CN · JP · EU

Asia–Europe Triangle

With roots in China, a base in Tokyo, and strong ties to European pharmaceutical markets, we bridge both directions: Asian manufacturers to European buyers, and vice versa.

Peptide Industry News

Latest developments in the global peptide and GLP-1 drug market.

LIVE
Novo Nordisk reports record GLP-1 sales growth — Q1 2026 China CDMO capacity for peptides expands 40% in 2025 Oral semaglutide Phase III results show strong efficacy EMA approves new GLP-1 receptor agonist for weight management Japanese government expands coverage for peptide-based therapies Eli Lilly tirzepatide now approved in 50+ countries Novo Nordisk reports record GLP-1 sales growth — Q1 2026 China CDMO capacity for peptides expands 40% in 2025 Oral semaglutide Phase III results show strong efficacy EMA approves new GLP-1 receptor agonist for weight management Japanese government expands coverage for peptide-based therapies Eli Lilly tirzepatide now approved in 50+ countries
Meet the Team

Our team combines deep expertise in pharmaceuticals, finance, and the Japanese healthcare market.

Jaisy Xu

Jaisy Xu

Founder & Managing Director

M.Sc. Financial Mathematics, Technical University of Munich
Over a decade of experience in the pharmaceutical industry
Active angel investor & enthusiastic entrepreneur

Hennessy Zhang

Hennessy Zhang

Partner & Pharmaceutical Consultant

Bachelor's degree in Pharmaceutical Management (China)
Master's degree in Business Administration (U.S.)
CFA Charterholder & Real Estate Appraiser

Contact Us

We'd love to hear about your project. Reach out and we'll be in touch shortly.

Send an Email
info@jandkl-jp.com
Tokyo, Japan